The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
OpenAI Employees Dropped More Than $296K on Democrats While Republicans Got Nothing, Filings Show
Trump DHS chief under fire from conservatives after immigration speech ignites backlash
Bryan Kohberger’s former defense expert calls for death penalty, says investigators missed key evidence
Would-Be Burglar Picked The Wrong North Carolina House To Break Into
GOP Rep Max Miller pushes back against abuse allegations: ‘I have nothing to hide’
Southern university requires business suits, bans du-rags and other headwear in new dress code
Trump demand puts vulnerable Republicans in impossible spot ahead of midterms
Anti-Violence Activist Allegedly Stabs Woman With Box Cutter
Obama Granted Bill Gates Top Secret Clearance At Energy Department
Fauci’s diary details how his relationship with Trump soured
It’s OK to be nostalgic about Woody Allen’s ‘Midnight in Paris’
Brewing conflict within the anti-Houthi coalition risks blowing up the US strategy in Yemen
The race to replace Gretchen Whitmer in Michigan
Inside the behemoth Smithsonian museum network drawing fire from the Trump administration
Vulnerable Democrat warns party to ‘fight back’ against growing socialist movement
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
OpenAI Employees Dropped More Than $296K on Democrats While Republicans Got Nothing, Filings Show
Trump DHS chief under fire from conservatives after immigration speech ignites backlash
Bryan Kohberger’s former defense expert calls for death penalty, says investigators missed key evidence
Would-Be Burglar Picked The Wrong North Carolina House To Break Into
GOP Rep Max Miller pushes back against abuse allegations: ‘I have nothing to hide’
Southern university requires business suits, bans du-rags and other headwear in new dress code
Trump demand puts vulnerable Republicans in impossible spot ahead of midterms
Anti-Violence Activist Allegedly Stabs Woman With Box Cutter
Obama Granted Bill Gates Top Secret Clearance At Energy Department
Fauci’s diary details how his relationship with Trump soured
It’s OK to be nostalgic about Woody Allen’s ‘Midnight in Paris’
Brewing conflict within the anti-Houthi coalition risks blowing up the US strategy in Yemen
The race to replace Gretchen Whitmer in Michigan
Inside the behemoth Smithsonian museum network drawing fire from the Trump administration
Vulnerable Democrat warns party to ‘fight back’ against growing socialist movement
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
